Cambridge, United Kingdom

Hanif Ali

This inventor holds 2 USPTO granted patents and 9 published patent applications and 3 EPO patents. Top assignee: Kymab Limited. Active years: 2020-2024.

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2020-2024

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Inventor Hanif Ali

Introduction

Hanif Ali is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of biotechnology, particularly in the development of methods for genetic manipulation. With a total of 2 patents, his work focuses on innovative techniques for introducing genetic modifications in organisms.

Latest Patents

Hanif Ali's latest patents include groundbreaking inventions in the realm of genetic engineering. One patent describes methods, cells, and organisms that relate to an approach for introducing one or more desired insertions and/or deletions of known sizes into predefined locations in a nucleic acid. This invention allows for precise modifications in a cell or organism's genome, utilizing techniques that either insert a discrete DNA fragment or carry out deletions at specific locations. The method is based on the observation that DNA single-stranded breaks are preferentially repaired through the HDR pathway, enhancing efficiency compared to prior art techniques.

Another significant patent involves the creation of transgenic non-human vertebrates for the in vivo production of dual specificity immunoglobulins or hypermutated heavy chain-only immunoglobulins. This invention introduces a novel concept of guided selection of antibody variable domains, enabling the production of multivalent polypeptides entirely in vivo. The focus is on heavy chain-only antibodies that lack light chains, along with the selection and maturation of these antibodies in non-human vertebrates.

Career Highlights

Hanif Ali is currently associated with Kymab Limited, where he continues to push the boundaries of genetic research and innovation. His work has the potential to revolutionize therapeutic approaches in immunology and genetic engineering.

Collaborations

He collaborates with esteemed colleagues, including E-Chiang Lee and Volker Germaschewski, to further enhance the impact of his research and inventions.

Conclusion

Hanif Ali's contributions to biotechnology through his innovative patents demonstrate his commitment to advancing genetic engineering techniques. His work not only showcases his expertise but also holds promise for future applications in medicine and research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…